Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THE PHOENIX STUDY
NCT00235222Phase 4Unknown
- Sponsor
- La Pitié-Salpêtrière Hospital
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of stavudine in human immunodeficiency virus infection (HIV), sponsored by La Pitié-Salpêtrière Hospital. Primary endpoint: Proportion of patients with viral load < 400 copies/ml at 24 weeks. Status: unknown.
02
Drugs
stavudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00235222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235222.